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The transcapillary escape rate of albumin (TERnIb) i.e., 
the fraction of intravascular albumin, that passes to the 
extravascular space per unit time is a parameter of the 
leakage of macromolecules from the total microvascu-
lature . 
In this study TERnn, was m easured before and after 
PUV A treatment to psoriatic patients to study functional 
alterations in the microvasculature induced by the treat-
ment. Short-term PUV A treatment caused a statistically 
significant increase in TERnl" in 7 out of 8 patients (p < 
0.05). This seems to be a functional equivalent to the 
morphological changes in the dermal capillary of pso-
riatic skin and the ultrastructural changes in the dermal 
vessel walls described after PUV A treatment. 
It suggests, that the amorphous p erivascular masses 
described in the p soriatic skin after PUV A treatment 
might be plasmatic substances deposited in and around 
the vessel wall as a result of increased vascular perme-
abili ty. 
In the psoriatic skin there are abnormally large endothelial 
gaps in th e venous capilla ri es and venules [1 ,2], and in a case of 
severe pustular psoriasis with hypoalbuminaemia it was sug-
gested, that albumin was being lost through this leaky vascu-
lature [3], In the light of these ul t rastructural ch anges func-
tional alteration of the escape rate of plasma proteins from the 
microvasculature of the psoriatic skin could be expected. 
T he transcap illal'y escape rate of albumin (TER"II') i.e., the 
fra ction of intravascular mass of albumin, that passes to the 
extravascular space per unit t ime is a parameter of the leakage 
to macromolecules in the microvasculature [4,5]. TERulh is 
increased in patients with extensive sk in diseases and in burns 
[5,6]. 
In a group of patients with uncom plicated psoriasis we found 
normal escape rates [7]. However, it must be stressed , that th e 
TER"lb is a measure of the overall whole-body escape rate of 
a lbumin from the microvasculature. Increased leakage from t he 
vessels of the psoriatic plaques may therefore not be able to 
cause a measurable increase in the TER"II,. 
Following single exposure to the normal skin of relatively 
large doses of longwave ultraviolet ligh t (UV A, 320 to 400 nm) , 
Kumakiri, Hashimoto, and Willis [8] found pronounced dermal 
damage with widely open endothelia l gaps in the superfi cial 
dermal vessels. Considerin g the ultrastructural changes in th e 
psoriatic skin a nd th e effect of UV A on the dermis, it has been 
the purpose of this study to examine, whethe r treatm ent with 
psoralen fo llowed by UV A (PUV A) could al ter the overall 
TER"II, in patients with ps'oriasis. 
MATERIALS AND M ETHODS 
Five male and 3 female patients with at least 30% of the skin affected 
by psoria is vu lgaris were examined (Table n. None of the patients had 
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previously received the combined treatment 0 (' psoralen and UV A. The 
PUVA treatment was carried out according to the guidelines of the 
European Co-operative Clinical Trial-Oral 8-Methoxypsoralen Photo-
chemotherapy of Psoriasis [9]. T able I shows the doses of UV A based 
on skin typing and 8-methoxypsoralen, the latter being ad ministered in 
10 mg tablets 2 hl' before the exposure to UV A after a mg/ kg basi . 
The light system used in this study was a Waldman PUVA 400 lie-
down unit or a stand-up uni t equipped with 1.52 Phi li ps flu orescent 
tubes (Philips TL 40 W /09) . 
The P UV A treatment was given on 2 successive days with the 
investigative procedures being performed 1 week before the fU'st treat-
ment and one day after the second treatment:. Any medication was kept 
unaltered during this period and only bland topical treatment was 
allowed for the skin. 
The investigative procudure was the same as described in a previous 
report [7]. The patients were studied in the morning after at least 12 hI' 
of fasting and 30 min of rest in the supine position. Human serum 
albumin labeled electrolytica lly with 1:1 11 (code IK. 21 S, Institute for 
Atomic Energy, KjeUer, Norway) was used as tracer. About 5 /1Ci of 
the tracer was injected in to one arm vein, and 9 venous blood samples 
were drawn from the other arm (10, 15, 20, 30, 35, 50, 55 and 60 min 
after injection). The rad ioactivity of all plasma samples was expressed 
in relation to total prote in concentration as measured by refractometry 
to avoid errors due to accidental plasma volume changes between 
samplings. TEH"", was determined as the rate constant of the practi-
cally monoexponential decrease in specific plasma activi ty over the 
first 60 min after injection as calculated by the least squares method. 
Plasma volume was determined by extrapolation to time zero of the 
plasma disappearance curve of tracer albumin, and the injected volume 
of tracer measured by weighing. Plasma albumin concentration was 
measured according to Mancini, Carbonara, and Heremans [10]. The 
intravascular mass of albumin (lVM"",) equals plasma vo lume x plasma 
albumin concentration. 
The results before treatment were compared with those obtained in 
10 normal adults by exactly the same techniqu e. This control group 
matched the patients as to sex, age and surface aJ·ea. Wilcoxon's tests 
for pail'ed and unpaired observations were used for statistical evalua-
tion. 
RESULTS 
Table I gives the clinical data a nd the treatment doses. Two 
patients (case 2 and 8) showed up with a light pink generalized 
erythem a a nd moderate pruri tus at the second examination, 
following the PUV A treatment on 2 successive days. The tr eat-
ment did not cause clinical edema in a ny of the patients. Table 
II shows the results before (1) and after PUVA treatment (II). 
The pretreatment values of TER,,!\) a nd the plasma a lbumin 
concentrations did not differ significantly fro m those of the 
control group (p > 0.1). The slightly higher mean TERnlh value 
in the patient gr oup was du e to two patients having initial high 
values probably due to congestive heart failure (case 6) a nd 
dia betes melli tus (case 8) [11 ,12]. The other 6 patients had 
pretreatment TERulu values close to those of the control group. 
Among the patients the individual values of plasma volume 
a nd to a lesser degree IVMulh was lower than those of th e 
control group, bu t t he difference was not significan t (p > 0.1). 
The PUV A treatment caused a significant e levation of t he 
TERn!\) values in 7 out of 8 pa tients (p < 0.05). The treatment 
did not influence an initial abnormally high TER"II, value in one 
patient (case no 6). 
Plasma volume, plasm a a lbumin concentration and IVMulb 
were unaltered after PUV A treatment compared to the pre-
treatment values, 
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TAB LE I. Clinical data and initial PUVA treatm.ent doses in 8 patients with psoriasis 
9 
14 
15 
16 
17 
Case 
No. 
M ean 
±SD 
1 
2 
3 
4 
5 
6 
7 
8 
Controls (n = 10) 
M ean 
±SD 
Sex 
F 
M 
F 
F 
M 
M 
M 
M 
Age We ighL 
(yr) (kg) 
44 54 
65 90 
34 72 
32 64 
31 73 
69 75 
28 72 
69 118 
47 77 
18 19 
46 69 
14 12 
S kin UVA 8-meLhoxypsora len 
in volvernenl (%) (J / cm 2 ) (mg) 
65 3.0 30 
30 1.0 50 
30 2.0 40 
60 1.0 30 
35 2.5 40 
30 2.0 40 
30 3.0 40 
70 1.0 60 
/ TABLE II. Transcapillary escape rate of albumin (TER"".) , plasm a volum e: albumin and intravascular mass of albulllin (TVM"".) before (I) 
and after shari -term P UVA treatm ent (II) in 8 patients with psoriasis 
TER .. II • Plasma vo lume Album in IVM .. II , 
Case (% l VM X 111.- 1) (11 m 2) (gi l) (g / m ' ) 
No. 
II 11 II II 
1 6.4 8.0 1.55 1.66 50.9 41.6 79.0 68.9 
2 5.4 6.9 1.47 1.49 39.4 39.4 58.2 58.8 
3 5.5 6.8 1.72 1.64 32.4 36.1 55.7 59.3 
4 5.5 7.6 1.44 1.50 36.1 37.5 51.9 56.2 
5 5.2 5.6 1.48 1.64 46.4 44.5 71.4 76.2 
6 10.9" 10.9 1.45 1.47 42.8 41.8 62.0 61.4 
7 5.7 6.4 1.55 1.70 45.5 46.4 70.5 78.8 
8 8.8" 9.9 2.36 2.20 41.3 40.2 97.8 88.2 
Mea n G.7 7.8 1.63 1.66 41.9 40.9 68.3 68.5 
±SD 2.1 1.8 0.31 0.23 5.9 3.4 15.0 lUi 
P 
Con tro ls (n = 10) 
< 0.05 N.S. N.S. N.S. 
M ean 5.2 1.63 41.5 68.0 
±SD 1.I 0. 15 2.4 9.6 
P N.S. N.S. N.S. N.S. 
" Init ia l high TER,,'h values due to congestive hear t failure (case -6) a nd diabetes melli t us (case 8). 
DISCUSSION 
The beneficial effect of PUV A treatment in psoriasis is well 
established [9,13] and without acute clinical side reactions, if 
the guidelines for dosimetry are followed [9,14]. 
If the PUV A treatment includes relative large doses of UV A, 
erythema may arise, possibly due to du-ect effect upon the 
dermal blood vessels [15]. Histologic I changes with dilated 
dermal blood vessels and damage to the vessel walls have been 
described after PUV A treatment, when high doses of UV A 
were given to both normal and psoriatic skin [16]. Electron 
microscopic studies of untreated psoria tic skin have shown 
dilated capillaries with open endothelial cell junctions in the 
upper dermis [1,2], and it has been suggested, t hat a continu-
ously increased vascular permeability is present in the skin of 
the psoriatic patient [2]. 
S uch a localized leakage does not necessarily alter the TERall" 
which is a measure of the overall whole-body escape rate of 
albumin from the microvasculature. This might explain the 
result from om' previous study, where the TER",,, was found to 
be normal in patients with uncomplicated psoriasis [7]. It is also 
possible, that the degl'ee of leakiness depends on the type of 
psoriasis (stable 01' unstable), and that this is the reason, why 
even patients wi th as much as 75% of the skin involved with 
psoriasis-in the above mentioned study-had normal TERn II, 
values. 
The total skin mass is only about 6% of the body weight 
[17], whereas the albumin conten t in the skin is about 20% of 
the total albumin mass and about 33% of the extravascular 
albumin mass [18). 
In the light of this it could be anticipated, that generalized 
skin disease is associated with increased leakage to plasma 
macromolecular substances [6], and that exposure of the total 
skin surface to PUV A treatment can cause a measurable in-
crease in the overall escape rate of albumin as contirmed in this 
study. 
However , it must be stressed, that further studies must show, 
whether the PUV A induced leakiness of albumin from the 
microvasculature is a specific phenomenon of patients wi th 
psoriasis 01' if normal control subjects react in the sam e way. 
The doses of UV A used in the PUV A therapy are far from 
those known to cause histological dermal damage including the 
dermal vasculature [8, 16]. Therefore it seems reasonable to 
suggest, t hat the increased escape rate of albumin is a result of 
the combined treatment with 8-methoxypsoralen and UV A, 
rather than that of UVA alone. 
The unaltered lVMall, in spite of increased leakiness lead to 
the conclusion, that the lymphatic return rate increases suffi -
ciently to compensate the extravasation of plasma proteins. 
The erythema after PUVA treatment appears after 24-48 hI' 
with a peak at 72 hr. Therefore the patients were examined the 
day after the last exposure to PUV A, that was given on 2 
successive days, assuming that a possible effect on the vascu-
lature might then be on its highest. 
Kumakir i, Hashimoto, and Willis [8] observed, that single 
exposure of the normal skin to t-elatively large doses of UV A 
was followed by pronounced dermal damage with widely open 
endothelial gaps in the superficial dermal capillaries. Further-
more a heavy deposition of amorphous masses was seen around 
the superficial dermal blood vessels after repeated exposm'e to 
UV A. In a recent study by the same group [19] it was shown, 
that therapeutic doses of PUV A to the psoriatic skin was 
likewise followed by perivascular coating with an amorphous 
substance. It was suggested, t hat these amorphous masses are 
produced by the fibroblasts to protect the blood vessels from 
repeated exposure to UVA. Neither in t.hese nor in other studies 
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have t he composition of t hese amorphous masses been further 
examined. 
T he demonstration of a PUV A induced increase in t he nor-
mal plasma protein escape rate prompt us to suggest, t hat t he 
perivascu lar amorphous masses are a deposit ion of macromo-
lecular plasma substances. 
Lendrum has termed the deposition of plasma proteins within 
and around the blood vessel wall "plasmatic vasc ulosis" and 
argued, that it is a consequence of eit her excessive pressure in 
the vascul ar lumen as seen in hype rtension or of a 10calJy 
increased permeabili ty of t he vascula r lining as in dia betes 
melli tus [20]. 
T he suggestion, t hat the amorphous perivascular masses 
described after PUVA treatment is a resul t of "plasmatic vas-
cwosis" is substantiated by the fact, t hat t he T ER"lh in t his 
study was raised from ini t ial norma l values to a bnorma lly high 
values after PUV A treatment. 
It should be noted, that deposit ion of perivascular amorphous 
su bstance has also been described in the un treated skin of 
patients with psoriasis t hough to a lesser degree [19]. Increased 
local fibrinoid deposition [21] and deposition of IgG, IgA, IgM 
and complement [22,23] have been found in the psoriatic skin. 
In a recent study [23] it was suggested, t hat this deposit ion is 
only the secondary event of an increa 'ed vascula r permeability, 
and therefore rather the resul t of coagulation of plasma proteins 
than t hat of an antigen-antibody reaction. This could well be 
the case in spite of normal T ERnlh s ince the method is too 
coarse to show a bnormali t ies a ffec ting minor parts of the skin. 
Comparison of the diffe rent plasma protein concentrations 
from the in terstit ial t issue fluid of normal and psoriatic skin 
and immu noflu orescence studies in psoriatic skin biopsies fo-
cusing also on immunological inactive serum prote ins such as 
albumin might so lve the problem, whether the microvascula-
ture of the pso riatic skin is leaky to mac romolecules, and 
whether t he increased leakage afte r PUV A treatment can cause 
a subseq uent perivascular deposit ion of plasma proteins in the 
dermis . . 
I wish to tha nk Inge- Lise Rossing and Ulla Hannibal for skil ful 
tech nical assistance. 
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